مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

861
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EFFECTS OF CARNITINE SUPPLEMENT ON DYSLIPIDEMIA AND ANEMIA IN HEMODIALYSIS PATIENTS

Pages

  596-605

Abstract

 Background: CARNITINE deficiency is a common condition in patients on maintenance HEMODIALYSIS that contributes to DYSLIPIDEMIA, ANEMIA, and poor general health in these patients. We evaluated the effect of oral L-carnitine supplementation on lipid profile, ANEMIA, and QUALITY OF LIFE in HEMODIALYSIS patients. Methods: This randomized, double-blinded, placebo-controlled, trial was conducted on dyslipidemic patients on maintenance HEMODIALYSIS. Patients in the intervention group (n=24) received 1 g/d of L-carnitine and the placebo group (27 patients) were similarly taking placebo for 16 weeks.Concentrations of plasma triglycerides, total cholesterol, HDL (High density lipoprotein), LDL (Low density lipoprotein), hemoglobin, ERYTHROPOIETIN dose, and QUALITY OF LIFE (QOL or QUALITY OF LIFE, using Short-Form Health Survey) were measured at baseline and 8 and 16 weeks after the beginning of the intervention.Findings: After the intervention, there was a significant decrease in triglyceride (-31.1±38.7 mg/dl, P=0.001) and a significant increase in HDL (3.7±2.8 mg/dl, P<0.001) and hemoglobin (0.7±1.7 g/dl, P=0.037) concentrations in the CARNITINE groop. Decrease in total cholesterol concentration in the CARNITINE group was not statistically significant (-6.6±16.0 mg/dl, P=0.055). No significant change was seen in LDL concentration in any group (P>0.05). ERYTHROPOIETIN dose was significantly decreased in both the CARNITINE (-4750±5772 mg, P=0.001) and the placebo (-2000±4296 mg, P=0.033) groups. No improvement was observed in QOL scores or its domains in any group.Conclusion: In patients on maintenance HEMODIALYSIS, oral L-carnitine supplementation has significant beneficial effects on lipid profile. Also, it can increase hemoglobin concentration and subsequently reduce needed ERYTHROPOIETIN dose, but has no considerable effect on QUALITY OF LIFE in HEMODIALYSIS patients.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    EMAMI NAINI, AFSOON, MORADI, MAHNAZ, MORTAZAVI, MOJGAN, HADIZADEH, MEHDI, SHIRANI, FARHAD, GHOLAMREZAEI, ALI, & GHAFOURI, HAMED BASIR. (2011). EFFECTS OF CARNITINE SUPPLEMENT ON DYSLIPIDEMIA AND ANEMIA IN HEMODIALYSIS PATIENTS. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 29(139), 596-605. SID. https://sid.ir/paper/51220/en

    Vancouver: Copy

    EMAMI NAINI AFSOON, MORADI MAHNAZ, MORTAZAVI MOJGAN, HADIZADEH MEHDI, SHIRANI FARHAD, GHOLAMREZAEI ALI, GHAFOURI HAMED BASIR. EFFECTS OF CARNITINE SUPPLEMENT ON DYSLIPIDEMIA AND ANEMIA IN HEMODIALYSIS PATIENTS. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2011;29(139):596-605. Available from: https://sid.ir/paper/51220/en

    IEEE: Copy

    AFSOON EMAMI NAINI, MAHNAZ MORADI, MOJGAN MORTAZAVI, MEHDI HADIZADEH, FARHAD SHIRANI, ALI GHOLAMREZAEI, and HAMED BASIR GHAFOURI, “EFFECTS OF CARNITINE SUPPLEMENT ON DYSLIPIDEMIA AND ANEMIA IN HEMODIALYSIS PATIENTS,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 29, no. 139, pp. 596–605, 2011, [Online]. Available: https://sid.ir/paper/51220/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top